Altoida

Ukraine
Novovasylivka, Mykolaiv, Ukraine, 20003

Company profile

Altoida company profile

Altoida is creating a new gold standard in brain health with Precision Neurology. We're radically transforming the method for measuring brain function and diagnosing neurological disease, using just your smartphone or tablet. Our products are backed by more than 20 years of innovative research in digital biomarkers, augmented reality (AR), and artificial intelligence (AI). Altoida received FDA Breakthrough Device Designation in July 2021. Our first device is a Computerized Cognitive Assessment Aid that is classified as Class II, 510(k) exempt.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2016-01-01, Year

Headquarters

Postal code
20003
Country code
UA
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
9
Total equity funding
$22M
Last funding
Series A / $14M / 2022-03-30
Last equity funding
Series A / $14M
Investors
15
Lead investors
7
Founders
5
Articles
34

Founders and investors

Founders

Adrian LocherFabian WahleIoannis TarnanasMaximilian BüglerRichard Fischer

Lead investors

Alzheimer's Drug Discovery FoundationEisai InnovationFYRFLY Venture PartnersHikma VenturesM VenturesVenture KickWhitecap Venture Partners

Investors

b2ventureFYRFLY Venture PartnersVenture KickVI PartnersWhitecap Venture Partners